App-Quantinova.ai

3D printing aids simultaneous isolation of proximal and distal lung epithelial progenitors from individual mice

Alsafadi Hani N. - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Acquired immunodeficiency syndrome

N/A

Precision Cut Lung Slices (PCLS) Thickness has Limited Impact on Tissue Viability

Rebecca Stinson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Myeloid-derived suppressor cells in the blood of COVID-19 patients

Esmaeil Mortaz - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Effect of cigarette smoke extract on Th17 inflammation and the anti-inflammatory effect of glucocorticoids in human airway smooth muscle cells

Abdulrhman Alghamdi - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Glucocorticoid

UPF1 and STAU1 modulate rhinovirus pathophysiology contributing to impaired antiviral immunity in asthma

Rocio Teresa Martinez-Nunez - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Interferon

Effect of cigarette smoke extract on inflammatory cytokine and chemokine production in human airway smooth muscle cells

Mushabbab Alahmari - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Effect of cigarette smoke extract on IL-8 production and anti-inflammatory effect of corticosteroids in human airway smooth muscle cells

Mushabbab Alahmari - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Fluticasone

The anti-inflammatory effects of helminth-derived peptides in a model of endotoxin-induced acute lung injury

Sinéad Ryan - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Acute lung injury

N/A

Epidermal growth factor receptor in airway remodelling during allergic airway disease divergent roles during early life and adulthood?

Stölting Helen - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

IL-36? a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease

Jonathan R. Baker - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Profiling of COPD and IPF cytokine responses in human lung

Dhruma Thakker - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

A novel short isoform of ACE2 is expressed in ciliated airway epithelium and is induced by interferon and rhinovirus infection but not SARS-COV-2; implications for COVID-19 interferon treatment

Claire L Jackson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Interferon

Microfluidic single cell analysis of microRNA levels in small airway epithelial cells and fibroblasts from COPD patients

Vanessa Ho - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Identifying super-responders to benralizumab in severe asthma

David J Jackson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Benralizumab

Severe asthma outcomes over two years of therapy with mepolizumab

Lynn Elsey - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Mepolizumab

The relationship between eosinophils and reduction in major adverse cardiac events in ETHOS

Mona Bafadhel - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Seebri Breezhaler

First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial

Stefan Andreas - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Tailored psychological intervention for anxiety/depression in people with COPD (TANDEM): a randomised controlled trial

Steph Taylor - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Depression

N/A

Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD

Aniek Markus - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Mindfulness based cognitive therapy in poorly controlled asthma: Will patients attend and do they benefit?

Steven Smith - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Filters

45280 Abstracts